| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/29/2011 | US20110236374 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2 |
| 09/29/2011 | US20110236373 Method of detecting antibodies and antibody-hiv virion complexes |
| 09/29/2011 | US20110236347 Monoclonal Anti-Claudin 1 Antibodies for the Inhibition of Hepatitis C Virus Infection |
| 09/29/2011 | US20110236314 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | US20110236304 Structural variants of antibodies for improved therapeutic characteristics |
| 09/29/2011 | CA2831262A1 N-cadherin: target for cancer diagnosis and therapy |
| 09/29/2011 | CA2794483A1 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 09/29/2011 | CA2793877A1 Mutations associated with cystic fibrosis |
| 09/29/2011 | CA2793753A1 Antibodies to muc16 and methods of use thereof |
| 09/29/2011 | CA2793402A1 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies |
| 09/29/2011 | CA2791991A1 Anti-lrp6 antibodies |
| 09/29/2011 | CA2789074A1 Bispecific antibodies |
| 09/28/2011 | EP2369345A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 09/28/2011 | EP2369342A2 Fluorescent silica-based nanoparticles |
| 09/28/2011 | EP2369014A1 Compositions and methods for characterizing, regulating, diagnosing and treating cancer |
| 09/28/2011 | EP2368997A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368996A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368995A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368994A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368993A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368992A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368991A2 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368990A1 Method for isolation of soluble polypeptides |
| 09/28/2011 | EP2368914A1 Anti-5T4 antibodies and uses thereof |
| 09/28/2011 | EP2368913A2 Glyco-engineered antibodies |
| 09/28/2011 | EP2368912A1 Regulators of NFAT |
| 09/28/2011 | EP2368911A1 Optimized Fc variants and methods for their generation |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368907A2 Anti-Abeta antibodies and their use |
| 09/28/2011 | EP2368578A1 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 09/28/2011 | EP2368577A2 Methods for treating interleukin-6 related diseases |
| 09/28/2011 | EP2368576A2 Functionally reconstituted viral membranes containing adjuvant |
| 09/28/2011 | EP2368114A2 Prediction and prevention of preeclampsia |
| 09/28/2011 | EP2367851A1 Antibody-targeted carrier for contrast agents |
| 09/28/2011 | EP2367850A2 Human anti tshr antibodies |
| 09/28/2011 | EP2367849A1 Method for the treatment of neurodegenerative diseases |
| 09/28/2011 | EP2367844A2 Rsv f vlps and methods of manufacture and use thereof |
| 09/28/2011 | EP2367570A2 Antibodies to il-6 and use thereof |
| 09/28/2011 | EP2154536B1 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes |
| 09/28/2011 | EP2120915B1 Polyelectrolyte precipitation and purification of antibodies |
| 09/28/2011 | EP1937827B1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 09/28/2011 | EP1864131B1 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/28/2011 | EP1708751B1 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 09/28/2011 | EP1649041B1 Multimeric oxidoreductases |
| 09/28/2011 | EP1463531B1 Methods for inhibiting ocular processes |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP0777732B1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 09/28/2011 | CN1980956B Humanized antibody against S-surface antigen of hepatitis b virus |
| 09/28/2011 | CN1905899B EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 09/28/2011 | CN1787839B Polysaccharide - staphylococcal surface adhesion carrier protein conjugates for immunization against nosocomial infections |
| 09/28/2011 | CN1750843B Methods and compositions for inducing apoptosis in cancer cells |
| 09/28/2011 | CN1665842B Human IgM antibody inducing apoptosis in HIV-infected cells and remedy for HIV-infection |
| 09/28/2011 | CN102203290A Molecular marker for cancer stem cell |
| 09/28/2011 | CN102203286A Determination of immunoglobulin encoding nucleid acid |
| 09/28/2011 | CN102203258A TGF-b antagonist multi-target binding proteins |
| 09/28/2011 | CN102203135A Antibodies against sonic hedgehog homolog and uses thereof |
| 09/28/2011 | CN102203134A Vaccine compositions |
| 09/28/2011 | CN102203133A Human cytomegalovirus neutralizing antibodies and use thereof |
| 09/28/2011 | CN102203132A Compositions of PD-1 antagonists and methods of use |
| 09/28/2011 | CN102203124A Amyloid ss peptide analogues, oligomers thereof, processes for preparing and compositions comprising said analogues or oligomers, and their uses |
| 09/28/2011 | CN102203122A Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease |
| 09/28/2011 | CN102203121A Prevention, treatment and diagnosis of p.gingivalis infection |
| 09/28/2011 | CN102203119A Human catechol-o-methyltransferase (comt) assay |
| 09/28/2011 | CN102202692A Method for diagnosing cancers expressing the her2 receptor or its truncated variants |
| 09/28/2011 | CN102202655A Lyophilized formulatons of engineered anti-il-23p19 antibodies |
| 09/28/2011 | CN102199593A Method for linking sequences of interest |
| 09/28/2011 | CN102199575A Corn chlorotic mottle virus monoclonal antibody and application thereof |
| 09/28/2011 | CN102199216A New dendritic cell co-stimulatory molecules |
| 09/28/2011 | CN102199213A scFv antibody for detecting ciprofloxacin, gene coding same and application thereof |
| 09/28/2011 | CN102199212A Monoclonal antibody against mucus immunoglobulin in flounder and preparation method thereof |
| 09/28/2011 | CN102199211A Method and special enzyme-linked immunoassay kit for detecting cowpea trypsin inhibitor |
| 09/28/2011 | CN102199210A Anti-interleukin-8 antibody |
| 09/28/2011 | CN102199209A Anti-interleukin-8 antibody |
| 09/28/2011 | CN102199208A Universal medicine delivery system and preparation method thereof |
| 09/28/2011 | CN102199207A Preparation method for multiple mycoplasma monoclonal antibodies and multi-linked immunoassay reagent |
| 09/28/2011 | CN101818134B ppGalNAc-T20 antigen and preparation method of polyclonal antibody thereof |
| 09/28/2011 | CN101648998B Method for extracting human immune globulin from component I+III or component III |
| 09/28/2011 | CN101180316B High-level expression of recombinant antibody in a mammalian host cell |
| 09/28/2011 | CN101139574B LRP16 monoclonal antibody hybrid oncocyte strain and uses thereof |
| 09/27/2011 | US8026353 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases |
| 09/27/2011 | US8026351 Monocyte-derived nucleic acids and related compositions and methods |
| 09/27/2011 | US8026345 Characterization and identification of unique human adiponectin isoforms and antibodies |
| 09/27/2011 | US8026344 Targeted binding agents directed to uPAR and uses thereof |
| 09/27/2011 | US8026342 Compositions and methods for binding sphingosine-1-phosphate |
| 09/27/2011 | US8026208 Peptide tyrosinase inhibitors and uses thereof |
| 09/27/2011 | US8026109 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/27/2011 | US8026096 In vivo active erythropoietin produced in insect cells |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | US8026054 Antibodies against cells of fetal origin |
| 09/27/2011 | US8025885 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | US8025882 Interferon alpha antibodies and their uses |
| 09/27/2011 | US8025881 BMP antibodies and methods of treating kidney disease using the same |
| 09/27/2011 | US8025879 Modified glycoproteins and uses thereof |
| 09/27/2011 | US8025878 Protofibril selective antibodies and the use thereof |
| 09/27/2011 | US8025877 Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate |
| 09/27/2011 | US8025876 Antibodies against a peptide epitope of apolipoprotein B |
| 09/27/2011 | CA2558805C Anti-myostatin antibodies |
| 09/27/2011 | CA2453486C The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |